Assembly Biosciences
ASMB
34 hedge funds and large institutions have $37.2M invested in Assembly Biosciences in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 10 closing their positions.
90% more call options, than puts
Call options by funds: $211K | Put options by funds: $111K
40% more capital invested
Capital invested by funds: $26.7M → $37.2M (+$10.6M)
38% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 8
8% less funds holding
Funds holding: 37 → 34 (-3)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Top Buyers
Top Sellers
ASMB Hedge Fund Activity: Q4 2013 in Review
34 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2013, worth a combined $37.2M — up 40% from $26.7M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ASMB and 7 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 11 added.
The largest buyer was Visium Asset Management, adding an estimated $910K. The largest seller was Deutsche Bank, cutting an estimated $937K.
- 34 institutional investors held Assembly Biosciences (ASMB) as of Q4 2013, down from 37 in Q3 2013.
- Funds reported $37.2M of Assembly Biosciences stock for Q4 2013, up 40% quarter-over-quarter.
- 7 funds opened new Assembly Biosciences positions in Q4 2013 and 10 closed out, a net change of -3 holders.
- The largest Assembly Biosciences buyer in Q4 2013 was Visium Asset Management, an estimated $910K added.
- The largest Assembly Biosciences seller in Q4 2013 was Deutsche Bank, an estimated $937K sold.
Based on aggregated 13F filings for Q4 2013.